US Broker Ratings

Verona Pharma plc (VRNA) Stock Analysis: A Biotech Gem with 30% Upside Potential

Verona Pharma plc (NASDAQ: VRNA), a promising player in the biotechnology industry, is capturing the attention of investors with its innovative approach to treating respiratory diseases...

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Strong Buy with Potential 71.78% Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) continues to be a compelling choice for investors seeking opportunities within the biotechnology sector. Headquartered in Dublin, Ireland, Jazz specializes in..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 50% Potential Upside

Investors eyeing the healthcare sector may want to take a closer look at Molina Healthcare Inc (NYSE: MOH), a stalwart in providing managed healthcare services under..

Waters Corporation (WAT): Investor Outlook Highlights 11% Potential Upside in Healthcare Sector

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector, has caught the attention of investors with its promising analytical workflow solutions, which are making significant..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Capitalizing on a 14.83% Potential Upside

Investors eyeing the healthcare sector have a promising candidate in GE HealthCare Technologies Inc. (NYSE: GEHC), currently trading at $76.07. With an impressive potential upside of..

Ascendis Pharma (ASND) Investor Outlook: Exploring a 32.83% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) is drawing considerable attention in the biotechnology sector, not just for its innovative approach to addressing unmet medical needs, but also..

Labcorp Holdings Inc. (LH) Stock Analysis: Unveiling the Potential Upside in the Diagnostics Giant

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of..

Centene Corporation (CNC) Stock Analysis: Exploring a 129.66% Potential Upside in Healthcare

Centene Corporation (NYSE: CNC) stands out in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $16.58 billion, this U.S.-based company..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating a 2.25% Upside with Strategic Market Positioning

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is a prominent player in the medical distribution industry. With a substantial market cap of..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 43.96% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans industry, presents a compelling case for investors seeking substantial upside potential. With a current market..

Pfizer, Inc. (PFE) Stock Analysis: Unpacking a 15.20% Upside Potential Amidst Market Challenges

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to be a focal point for investors seeking stability in an otherwise volatile market. With..

Dr. Reddy’s Laboratories Ltd (RDY) Investor Outlook: Navigating Growth with a 20.10% Revenue Surge

Dr. Reddy’s Laboratories Ltd (RDY) stands at an intriguing juncture for investors, driven by its robust position in the healthcare sector and a remarkable 20.10% revenue..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Unveiling a 37.87% Potential Upside for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA) stands as a formidable player in the healthcare sector, specializing in the development, manufacturing, and distribution of generic and specialty..

Align Technology, Inc. (ALGN): Investor Outlook Reveals 18% Upside Potential Amid Market Volatility

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector, specializes in medical instruments and supplies. The company, headquartered in Tempe, Arizona, is renowned..

Incyte Corporation (INCY) Stock Analysis: Evaluating Its Potential Upside and Strong Revenue Growth

Investors eyeing the healthcare sector may want to take a closer look at Incyte Corporation (NASDAQ: INCY), a powerhouse in the biotechnology industry with a market..

Amgen Inc. (AMGN): Investor Outlook Shows Promising 5.37% Potential Upside

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector and a leading player in the drug manufacturing industry, offers compelling investment prospects for individual investors...

BeOne Medicines Ltd. (ONC): Consensus and Growth Potential in the Biotech Sector

Investors with an eye for biotechnology stocks are closely watching BeOne Medicines Ltd. (ONC), a Swiss-based oncology company that’s making waves with its innovative cancer treatments...

Solventum Corporation (SOLV) Stock Analysis: Assessing Growth Potential in the Healthcare Sector

Solventum Corporation (SOLV), a burgeoning player in the healthcare sector, has been attracting attention with its diverse portfolio and strategic approach to addressing critical patient needs..

AptarGroup, Inc. (ATR) Stock Analysis: A Look at Healthcare Sector’s Hidden Gem with 8.67% Upside

AptarGroup, Inc. (NYSE: ATR) might not be the most talked-about name on Wall Street, but for investors eyeing the healthcare sector, this Crystal Lake, Illinois-based company..

Sanofi (SNY) Investor Outlook: Exploring a 32% Upside Potential with Strong Dividend Yield

Sanofi (SNY), a cornerstone of the global healthcare sector, presents a compelling investment narrative with its robust dividend yield and significant upside potential. Headquartered in Paris,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds